P PRIMESTOCKFINDER.COM

MCK Stock McKesson Corporation

US · NYSE
$992.87 -0.79% Prices as of close 2026-10-26

Last in our picks 2026-10-15 — not in the current list; analysis below is from that screen

Pharmaceutical distribution momentum, biosimilar opportunity, and defensive demand support forward value.

Future value: $986.15 (+0.98%) · 6-12 months · analyst consensus

Signal breakdown

  • ▸Analyst fair-value estimates and targets remain elevated amid strong pharma demand.
  • ▸Above 50-day MA (+9.56%)
  • ▸Above 200-day MA — long-term uptrend
  • ▸Near 52-week high (91.9% of range) — strength

Is MCK a buy right now?

Trend: MCK is trading above the 50-day average (+8.80%), RSI 43 — neutral momentum, with a 3-month return of +11.62%.

Valuation & quality: McKesson Corporation trades on a trailing P/E of 26.6, forward P/E 19.6, PEG 1.88; fundamentals show net margin 1.1%, revenue growth 7.7% year on year.

Analyst consensus: 14 analysts have a mean 12-month price target of $1009.64 (+1.7% vs the last close; range $845.00 – $1200.00), consensus rating “buy”.

Income: trailing dividend yield 0.38%.

Our screen: STRONG BUY (score 4) — Pharmaceutical distribution momentum, biosimilar opportunity, and defensive demand support forward value.

Computed from end-of-day data; not personal advice.

12-month price chart

1030 725.2 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-09 → 2026-10-26 (USD). Range 725.2 – 1030.

Monthly returns

Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
-12.40%-5.80%-8.90%+1.80%+13.30%+3.40%-3.60%+16.30%

Fundamentals

Market cap
$115.76B
P/E (ttm)
26.6
Forward P/E
19.6
EPS (ttm)
$37.31
PEG
1.88
Beta
0.30
Net margin
1.1%
Revenue growth
7.7%
Earnings growth
-17.6%
Revenue (ttm)
$410.98B
Free cash flow
$6.80B
Dividend yield
0.38%
52-wk range
$723.68 – $1,030.27
Volume
508,175
Avg volume (3m)
892,939

Analyst price target

Mean target
$1,009.64
Low
$845.00
High
$1,200.00
Analysts
14
Consensus
BUY

Technical signals

RSI (14)
42.9
vs 50-day MA
+8.80%
1-mo return
+14.57%
3-mo return
+11.62%
Volume z-score
-0.34

About McKesson Corporation

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.

Sector: Healthcare · Industry: Medical Distribution · United States · 41,600 employees · Website

Related Health Care picks

BMRNBioMarin PharmaceuticaIONSIonis Pharmaceuticals,BSXBoston Scientific CorpSYKStryker CorporationUNHUnitedHealth Group IncHUMHumana Inc.BMYBristol-Myers Squibb CHNGEHinge Health, Inc.

Browse: all US stocks · Health Care picks · today's movers

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.